Remdesivir for Treating Non-Hospitalized Patients with COVID-19
Pakistan Journal of Medical and Health Sciences
; 16(2):156-157, 2022.
Article
in English
| EMBASE | ID: covidwho-1798527
ABSTRACT
Aim:
To examine the effect of remdesivir for treating non-hospitalized patients with COVID-19. Studydesign:
Retrospective study Place and duration of study Department of Medicine, Bolan Medical College, Quetta from 1st April 2021 to 30th September 2021.Methodology:
One hundred patients were enrolled and divided into group A and group B within the age of 24-70 years. Group A was receiving remdesivir while group B is not receiving remdesivir. The clinical variables, BMI, comorbidities, duration of disease severity and viral load were determined. RT-PCR was conducted to determine viral load.Results:
The mean age of study participants was 50±15 years with greater number of males. Diabetes was the major comorbidity. The time duration was decreased in group A upto 5 days and 8 days in group B. The viral load was decreased by mean value 6.32±1.76 to 6.2±1.78 in group B then group A respectively.Conclusion:
Remdesivir is effective in COVID-19 treatment.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Pakistan Journal of Medical and Health Sciences
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS